RACHAEL MCCORMICK: Open Payments
NPI 1609369180 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 27 payments from 10 companies in 2025. Trend: 2023 $455 · 2024 $705 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 2 | $144 |
| CSL Behring | 6 | $130 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| GlaxoSmithKline, LLC. | 4 | $77 |
| JAZZ PHARMACEUTICALS INC. | 3 | $68 |
| GENZYME CORPORATION | 2 | $49 |
| Optinose US, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Pharming Healthcare, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
Products named: NEFFY, DUPIXENT, Hizentra, NUCALA, XYWAV, Andembry, Xhance, TAKHZYRO.
Industry payments across NY — which companies pay providers there.
